Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies

α-Synuclein (asyn) is a key pathogenetic factor in a group of neurodegenerative diseases generically known as synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Although the initial triggers of pathology and progression are...

Full description

Bibliographic Details
Main Authors:	Sindhu Menon, Sabrina Armstrong, Amir Hamzeh, Naomi P. Visanji, Sergio Pablo Sardi, Anurag Tandon
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Neurology
Subjects:	Parkinson's disease prion gene therapy anti-aggregation brain delivery of drugs immunization
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.852003/full

Similar Items

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
by: Naomi P. Visanji, et al.
Published: (2019-09-01)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
by: Inês C. Brás, et al.
Published: (2021-02-01)

Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
by: Figeys Daniel, et al.
Published: (2008-09-01)

Retraction Note to: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
by: Sabine Wislet-Gendebien, et al.
Published: (2021-06-01)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
by: Guoxin Zhang, et al.
Published: (2018-11-01)

The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
by: Asad Jan, et al.
Published: (2021-08-01)

α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration
by: Hisham Abdelmotilib, et al.
Published: (2017-09-01)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
by: Alessandra Bigi, et al.
Published: (2023-01-01)

Alpha-Synuclein Aggregation in Parkinson's Disease
by: E. Srinivasan, et al.
Published: (2021-10-01)

α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
by: Simon Oliver Hoppe, et al.
Published: (2021-06-01)

Alpha-Synuclein spreading in Parkinson disease
by: Ariadna eRecasens, et al.
Published: (2014-12-01)

Calcium: alpha-synuclein interactions in alpha-synucleinopathies
by: Alexandre N. Rcom-H’cheo-Gauthier1, et al.
Published: (2016-12-01)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01)

Solubility of α-synuclein species in the L62 mouse model of synucleinopathy
by: Karima Schwab, et al.
Published: (2024-03-01)

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson’s disease
by: Daniel Kam Yin Chan, et al.
Published: (2017-12-01)

Internalization, axonal transport and release of fibrillar forms of alpha-synuclein
by: Gregor Bieri, et al.
Published: (2018-01-01)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson’s Disease
by: Valentina Gilmozzi, et al.
Published: (2020-10-01)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
by: Mónica Gómez-Benito, et al.
Published: (2020-04-01)

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
by: Kamil Saramowicz, et al.
Published: (2023-12-01)

Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
by: Maxime Teixeira, et al.
Published: (2021-09-01)

Differential Aggregation and Phosphorylation of Alpha Synuclein in Membrane Compartments Associated With Parkinson Disease
by: Ana Canerina-Amaro, et al.
Published: (2019-04-01)

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
by: Zachary A. Sorrentino, et al.
Published: (2017-05-01)

Gut-to-Brain α-Synuclein Transmission in Parkinson’s Disease: Evidence for Prion-like Mechanisms
by: Merry Chen, et al.
Published: (2023-04-01)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
by: Hao Gu, et al.
Published: (2021-03-01)

Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies
by: Tritia R. Yamasaki, et al.
Published: (2020-05-01)

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
by: Chao Peng, et al.
Published: (2018-01-01)

Colonic mucosal -synuclein lacks specificity as a biomarker for Parkinson disease
by: Ruffmann, C, et al.
Published: (2015)

Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models
by: Alice Drobny, et al.
Published: (2023-06-01)

Cross-Reactivity and Sequence Homology Between Alpha-Synuclein and Food Products: A Step Further for Parkinson’s Disease Synucleinopathy
by: Aristo Vojdani, et al.
Published: (2021-05-01)

Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
by: Megan F. Duffy, et al.
Published: (2018-09-01)

α-Synuclein Regulates Peripheral Insulin Secretion and Glucose Transport
by: Nadeeja Wijesekara, et al.
Published: (2021-07-01)

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
by: Sonia George, et al.
Published: (2019-08-01)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
by: Danzer Karin M, et al.
Published: (2012-08-01)

Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
by: Naomi P. Visanji, et al.
Published: (2009-08-01)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
by: Akio Sekigawa, et al.
Published: (2015-05-01)

The relationship of alpha-synuclein to mitochondrial dynamics and quality control
by: Naomi J. Thorne, et al.
Published: (2022-08-01)

The effects of post-translational modifications on alpha-synuclein aggregation and immune cell activation in Parkinson’s disease
by: Zaina Khan, et al.
Published: (2023-10-01)

Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight
by: Mohammed Al-Azzani, et al.
Published: (2022-02-01)

Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
by: Veronica Ghiglieri, et al.
Published: (2018-05-01)